Ownership history in UBS Group AG · 4 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in 60 DEGREES PHARMACEUTICALS I (SXTP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 1,476 | — | 0% | 0.00% | $750 | $2.03 |
| 2025 Q3 | ADDED | 1,476 | +1,462 | +10442.9% | 0.00% | $2K | $5.92 |
| 2025 Q2 | REDUCED | 14 | -16,174 | -99.9% | 0.00% | $33 | $9.48 |
| 2025 Q1 | INITIATED | 16,188 | — | — | 0.00% | $30K | $7.36 |
As of 2025 Q4 — sorted by position size